Valiant Laboratories IPO Day 3: Check GMP Today, Subscription Status - News18

[ad_1]

Reported By: Mohammad Haris

Last Updated: September 29, 2023, 08:10 IST

Valiant Laboratories IPO: GMP, Price, Subscription, all you need to know.

Valiant Laboratories IPO: GMP, Price, Subscription, all you need to know.

Unlisted shares of Valiant Laboratories Ltd remain Rs 17 higher in the grey market as compared to its issue price

Valiant Laboratories IPO: The initial public offering (IPO) of pharmaceutical ingredient manufacturing firm Valiant Laboratories, which will conclude today, Friday, September 29, was subscribed 71 per cent on the second day of bidding on Thursday. The Rs 152.46-crore IPO received bids for 54,25,770 shares against 76,23,030 units on offer.

The category for retail individual investors (RIIs) was subscribed 1.27 times, while the quota for non-institutional investors received 29 per cent subscription. The portion for qualified institutional buyers (QIBs) was subscribed 5 per cent.

Valiant Laboratories IPO GMP Today

According to market observers, unlisted shares of Valiant Laboratories Ltd remain Rs 17 higher in the grey market as compared to its issue price. The Rs 17 grey market premium or GMP is about 12.14 per cent higher than its upper issue price of Rs 140 per share. This means the grey market is expecting a 12.14 per cent listing gain from the public issue.

‘Grey market premium’ indicates investors’ readiness to pay more than the issue price.

Valiant Laboratories IPO Details

The IPO was opened for public subscription on September 27, and will conclude today. It is an entirely fresh issuance of up to 1.08 crore equity shares with no offer-for-sale component.

The price range for the offer is Rs 133-140 a share. Investors can bid for a minimum of 69 shares and in multiples thereof.

The proceeds of the issue will be utilised to set up a manufacturing facility for speciality chemicals in Gujarat through its subsidiary — Valiant Advanced Sciences Private Ltd. — and to meet the working capital requirements of the subsidiary company.

Valiant Laboratories is an active pharmaceutical ingredient or bulk drug manufacturing company with its focus on manufacturing paracetamol, used in the treatment of headaches, muscle aches, arthritis, backache, toothache, cold and fever.

Unistone Capital is the manager to the offer.

Equity shares of the company will be listed on the BSE and the NSE.

Mohammad Haris
Haris is Deputy News Editor (Business) at News18.com. He writes on various issues related to markets, economy and companies....Read More
[ad_2] Source link https://worldnews2023.com/economy/valiant-laboratories-ipo-day-3-check-gmp-today-subscription-status-news18/?feed_id=324191&_unique_id=673530e6db53c

Comments

Post a Comment

Popular posts from this blog

Real Housewives of Beverly Hills couple Kyle Richards and Mauricio Umansky ‘seperate’

Image
[ad_1] Stay ahead of the trend in fashion and beyond with our free weekly Lifestyle Edit newsletter Stay ahead of the trend in fashion and beyond with our free weekly Lifestyle Edit newsletter Real Housewives of Beverly Hills ’ Kyle Richards and Mauricio Umansky have reportedly separated after 27 years of marriage. Richards joined the popular Bravo reality series in 2010 with Umansky making regular appearances over the last 13 years. “Kyle and Mauricio have been separated for a while now but are still living under the same roof. They remain amicable as they figure out what’s next for them and their family,” a source confirmed to People on Monday (3 July). The separation will affect both Real Housewives , which is gearing up for its 13th season, and the Netflix reality series Buying Beverly Hills, which follows Umansky’s real estate business as two of their daughters work as agents. Richards has already filmed the second season of the Netflix show, according to Deadline . The I
Read more

Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say

Image
[ad_1] Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images U.S. Food and Drug Administration staff on Tuesday said Pfizer's vaccine that protects infants from respiratory syncytial virus has "generally favorable" safety data. The FDA staff made the conclusion in briefing documents ahead of a meeting on Thursday when a panel of external advisors to the agency will discuss whether to recommend full approval of the RSV shot . The advisors will vote on whether Pfizer's late-stage clinical trial data on the vaccine supports its safety and efficacy. The FDA typically follows the advice of its advisory committees, but is not required to do so. The agency is slated to make a decision on whether to clear the shot in August before RSV season in the fall. If approved, Pfizer's jab would become the world's first vaccine that protects infants against RSV.  RSV usually causes mild, cold-like symptoms. But infants and older ad
Read more

Casemiro has improved Man Utd: Maguire | The Express Tribune

Image
[ad_1] LONDON: Casemiro scored twice as Manchester United turned on the style to beat 10-man Reading 3-1 and reach the FA Cup fifth round on Saturday as Tottenham forward Son Heung-min ended his recent goal drought. On a day lacking major shocks, there were wins for Premier League strugglers Leeds, Leicester and Southampton but Fulham were held by Championship side Sunderland. United – fourth in the Premier League and within touching distance of a place in the League Cup final – produced more compelling evidence they are back on track under new manager Erik ten Hag . The home side took the lead at Old Trafford in the 54th minute when Anthony produced a defence-splitting pass to find Brazil teammate Casemiro, who lifted the ball over goalkeeper Joe Lumley. Four minutes later United were two up, when Casemiro let fly with a stunning strike from outside the box to find the bottom corner. With the home side brimming with confidence, substitute Fred produced an audacious flic
Read more